Webinar

Continuous Improvement: Quality Culture from the Top Down


Regulatory Compliance Associates Executive Head of Pharmaceuticals, Steven J. Lynn M.S., had the honor of being the FDAnews GMP Quality Management vSummit 2023 Summit Chairperson. This annual summit consisted of the top industry experts on developing a world-class QMS that uses the most up-to-date good manufacturing practices.

During the summit RCA’s Distinguished Fellow and  2023 Board of Directors Chair for the Parenteral Drug Association (PDA) Susan Schniepp had the opportunity to present Building a Culture of Quality from the Top Down– A Companywide Attitude of Excellence.

The culture of an organization is critical to ensuring its products are manufactured with patient safety and product quality concepts at the forefront. This session will focus on some of the attributes needed in a quality culture to achieve this vision as well as discussing some of the pitfalls that prevent a true culture of quality from being achieved.

Please note that functional cookies must be enabled to access this content.

Register to Watch the Webinar

    Presenters

    Susan Schniepp

    Susan Schniepp

    RCA Distinguished Fellow

    With more than 40 years of industry experience in quality control and quality assurance, Sue has had responsibilities for complaints, labeling, investigations, compendial affairs, and other quality systems. In addition to RCA, she has held leadership roles at Allergy Laboratories, Inc.; OsoBio Pharmaceuticals, LLC; Searle; Abbott; and Hospira.

    She has served the Parenteral Drug Association (PDA) as a member of the Board of Directors, PDA / FDA Joint Regulatory Affairs Conference Chair, conference presenter, and Chair of PDA's Regulatory Affairs / Quality Advisory Board. She was also awarded PDA's Distinguished Service Award in 2008.